Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
ArticleAbstract: Background-Clinical trials in heart failure have focused on the improvement in symptoms or decreasesPalabras claves:Angiotensin, Heart Failure, Neprilysin, ReceptorsAutores:Andersen K., Arango J.L., Arnold J.M., Belohlávek J., Böhm M., Boytsov S., Burgess L.J., Cabrera W., Calvo C., Chen C.H., Desai A.S., Dukat A., Erglis A., Fu M., Gomez E., Gong J., Gonzàlez-Medina A., Hagège A.A., Huang J., Katova T., Kiatchoosakun S., Kim K.S., Kozan Ö., Lefkowitz M.P., Llamas E.B., Martinez F., McMurray J.J.V., Mendoza I., Merkely B., Mosterd A., Negrusz-Kawecka M., Packer M., Peuhkurinen K., Ramires F.J.A., Refsgaard J., Rizkala A.R., Rosenthal A., Rouleau J.L., Senni M., Shi V.C., Sibulo A.S., Silva-Cardoso J., Solomon S.D., Squire I.B., Starling R.C., Swedberg K., Teerlink J.R., Vanhaecke J., Vinereanu D., Wong R.C.C., Yan Duarte, Zile M.Fuentes:scopusLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
ArticleAbstract: Background: Guidelines recommend nonstatin lipid-lowering agents in patients at very high risk for mPalabras claves:acute coronary syndrome, lipoprotein(a), low-density lipoprotein cholesterol, PCSK9 inhibitorAutores:Alexander J.H., Alexander K., Alings M., Armaganijan L., Aylward P.E., Bagai A., Bahit M.C., Bhatt D.L., Bittner V.A., Brennan J.M., Budaj A.J., Chaitman B., Chiang C.E., Chua T., Chumburidze V., Clifton S., Correa Flores R.M., Dalby A.J., Danchin N., De Silva H.A., Deloatch S., Devore A.D., DIaz R., Dickey S., Dilic M., Dombrowski K., Dorobantu M., Drexel H., Edelberg J.M., Erglis A., Fras Z., Goodman S.G., Gotcheva N.N., Guneri S., Hagström E., Halvorsen S., Hanotin C., Harrington R.A., Jukema J.W., Karpov Y., Kedev S., Kelsey S.F., Kim H.S., Kim S.H., Kimura T., Kiss R.G., Landmesser U., Laucevicius A., Lecorps G., Liberopoulos E., Lopes R.D., Mahaffey K.W., Manvelian G., Marx N., Meloni C., Montenegro Valdovinos P.C., Morais J., Moriarty P.M., Moryusef A., Müller C.E., Murin J., Nieminen M.S., Olsson A.G., Ostadal P., Parkhomenko A.N., PATRICIO LOPEZ -JARAMILLO, Pecin I., Pordy R., Poulsen S.H., Prieto J.C., Ramos López G.A., Ray K.K., Reiner Z., Ristic A.D., Roe M.T., Rosenson R., Rouleau J.L., Sasiela W.J., Scemama M., Schwartz G.G., Sijbrands E.J.G., Simoons M.L., Sinnaeve P.R., Sritara P., Steg P.G., Sy R.G., Szarek M., Tamby J.F., Tricoci P., Tse H.F., Tuñón J., Valgimigli M., Viigimaa M., Vogel R., White H.D., Xavier D., Yong H., Yusoff K., Zahger D., Zeiher A.M.Fuentes:googlescopus